- Report
- January 2026
- 187 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- May 2025
- 126 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- May 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2025
- 260 Pages
Global
From €4375EUR$4,995USD£3,797GBP
Tavaborole is a topical antifungal drug used to treat fungal infections of the skin, such as athlete's foot, jock itch, and ringworm. It is a member of the boron-containing antifungal class of drugs, and is available in both prescription and over-the-counter forms. Tavaborole is used to treat a variety of fungal infections, including those caused by Candida, Trichophyton, and Epidermophyton species. It is also used to treat onychomycosis, a fungal infection of the nails.
Tavaborole is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is generally well-tolerated, with few side effects. It is also relatively inexpensive, making it an attractive option for those who cannot afford more expensive treatments.
The Tavaborole market is highly competitive, with a number of companies offering products containing the drug. These include Bayer, Novartis, Merck, Pfizer, and GlaxoSmithKline. Show Less Read more